|
1
|
Jia G, Hill MA and Sowers JR: Diabetic
cardiomyopathy: An update of mechanisms contributing to this
clinical entity. Circ Res. 122:624–638. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Wong TY, Cheung CM, Larsen M, Sharma S and
Simo R: Diabetic retinopathy. Nat Rev Dis Primers.
2(16012)2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Shi Y and Vanhoutte PM: Macro- and
microvascular endothelial dysfunction in diabetes. J Diabetes.
9:434–449. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Testa R, Bonfigli AR, Prattichizzo F, La
Sala L, De Nigris V and Ceriello A: The ‘Metabolic Memory’ theory
and the early treatment of hyperglycemia in prevention of diabetic
complications. Nutrients. 9(437)2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Giacco F and Brownlee M: Oxidative stress
and diabetic complications. Circ Res. 107:1058–1070.
2010.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Chilelli NC, Burlina S and Lapolla A:
AGEs, rather than hyperglycemia, are responsible for microvascular
complications in diabetes: A ‘glycoxidation-centric’ point of view.
Nutr Metab Cardiovasc Dis. 23:913–919. 2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Reddy MA, Zhang E and Natarajan R:
Epigenetic mechanisms in diabetic complications and metabolic
memory. Diabetologia. 58:443–455. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Reddy MA and Natarajan R: Epigenetic
mechanisms in diabetic vascular complications. Cardiovasc Res.
90:421–429. 2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Thompson JA and Webb RC: Potential role of
Toll-like receptors in programming of vascular dysfunction. Clin
Sci (Lond). 125:19–25. 2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhang HN, Xu QQ, Thakur A, Alfred MO,
Chakraborty M, Ghosh A and Yu XB: Endothelial dysfunction in
diabetes and hypertension: Role of microRNAs and long non-coding
RNAs. Life Sci. 213:258–268. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Leung A, Amaram V and Natarajan R: Linking
diabetic vascular complications with LncRNAs. Vascul Pharmacol.
114:139–144. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Biswas S, Thomas AA and Chakrabarti S:
LncRNAs: Proverbial genomic ‘Junk’ or key epigenetic regulators
during cardiac fibrosis in diabetes? Front Cardiovasc Med.
5(28)2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Kung JT, Colognori D and Lee JT: Long
noncoding RNAs: Past, present, and future. Genetics. 193:651–669.
2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zhang X, Hong R, Chen W, Xu M and Wang L:
The role of long noncoding RNA in major human disease. Bioorg Chem.
92(103214)2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Singh KK, Mantella LE, Pan Y, Quan A,
Sabongui S, Sandhu P, Teoh H, Al-Omran M and Verma S: A global
profile of glucose-sensitive endothelial-expressed long non-coding
RNAs. Can J Physiol Pharmacol. 94:1007–1014. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Xu E, Hu X, Li X, Jin G, Zhuang L, Wang Q
and Pei X: Analysis of long non-coding RNA expression profiles in
high-glucose treated vascular endothelial cells. BMC Endocr Disord.
20(107)2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Leung A and Natarajan R: Long noncoding
RNAs in diabetes and diabetic complications. Antioxid Redox Signal.
29:1064–1073. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Thomas AA, Feng B and Chakrabarti S:
ANRIL: A regulator of VEGF in diabetic retinopathy. Invest
Ophthalmol Vis Sci. 58:470–480. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Yan B, Yao J, Liu JY, Li XM, Wang XQ, Li
YJ, Tao ZF, Song YC, Chen Q and Jiang Q: lncRNA-MIAT regulates
microvascular dysfunction by functioning as a competing endogenous
RNA. Circ Res. 116:1143–1156. 2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Liu JY, Yao J, Li XM, Song YC, Wang XQ, Li
YJ, Yan B and Jiang Q: Pathogenic role of lncRNA-MALAT1 in
endothelial cell dysfunction in diabetes mellitus. Cell Death Dis.
5(e1506)2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Qiu GZ, Tian W, Fu HT, Li CP and Liu B:
Long noncoding RNA-MEG3 is involved in diabetes mellitus-related
microvascular dysfunction. Biochem Biophys Res Commun. 471:135–141.
2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zhang D, Qin H, Leng Y, Li X, Zhang L, Bai
D, Meng Y and Wang J: LncRNA MEG3 overexpression inhibits the
development of diabetic retinopathy by regulating TGF-β1 and VEGF.
Exp Ther Med. 16:2337–2342. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zhang E, Guo Q, Gao H, Xu R, Teng S and Wu
Y: Metformin and resveratrol inhibited high glucose-induced
metabolic memory of endothelial senescence through
SIRT1/p300/p53/p21 pathway. PLoS One. 10(e0143814)2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Jin G, Wang Q, Pei X, Li X, Hu X, Xu E and
Li M: mRNAs expression profiles of high glucose-induced memory in
human umbilical vein endothelial cells. Diabetes Metab Syndr Obes.
12:1249–1261. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Kim D, Langmead B and Salzberg SL: HISAT:
A fast spliced aligner with low memory requirements. Nat Methods.
12:357–360. 2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Pertea M, Kim D, Pertea GM, Leek JT and
Salzberg SL: Transcript-level expression analysis of RNA-seq
experiments with HISAT, StringTie and Ballgown. Nat Protoc.
11:1650–1667. 2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Pertea M, Pertea GM, Antonescu CM, Chang
TC, Mendell JT and Salzberg SL: StringTie enables improved
reconstruction of a transcriptome from RNA-seq reads. Nat
Biotechnol. 33:290–295. 2015.PubMed/NCBI View
Article : Google Scholar
|
|
28
|
Nikolayeva O and Robinson M: edgeR for
differential RNA-seq and ChIP-seq analysis: An application to stem
cell biology. Methods Mol Biol. 1150:45–79. 2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Wang C and Li Q, Yang H, Gao C, Du Q,
Zhang C, Zhu L and Li Q: MMP9, CXCR1, TLR6, and MPO participant in
the progression of coronary artery disease. J Cell Physiol.
235:8283–8292. 2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Ashburner M, Ball C, Blake J, Botstein D,
Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et
al: Gene ontology: Tool for the unification of biology. The gene
ontology consortium. Nat Genet. 25:25–29. 2000.PubMed/NCBI View
Article : Google Scholar
|
|
31
|
Yu G, Wang L, Han Y and He Q:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Livak K and Schmittgen T: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Knauss JL and Sun T: Regulatory mechanisms
of long noncoding RNAs in vertebrate central nervous system
development and function. Neuroscience. 235:200–214.
2013.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Singh R, Chandel S, Dey D, Ghosh A, Roy S,
Ravichandiran V and Ghosh D: Epigenetic modification and
therapeutic targets of diabetes mellitus. Biosci Rep.
40(BSR20202160)2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Berezin A: Metabolic memory phenomenon in
diabetes mellitus: Achieving and perspectives. Diabetes Metab
Syndr. 10 (2 Suppl 1):S176–S183. 2016.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Yamagishi S, Fukami K and Matsui T:
Crosstalk between advanced glycation end products (AGEs)-receptor
RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic
vascular complications. Cardiovasc Diabetol. 14(2)2015.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Yamagishi S and Matsui T: Role of receptor
for advanced glycation end products (RAGE) in liver disease. Eur J
Med Res. 20(15)2015.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Koulis C, Watson AMD, Gray SP and
Jandeleit-Dahm KA: Linking RAGE and Nox in diabetic micro- and
macrovascular complications. Diabetes Metab. 41:272–281.
2015.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Choi HJ and Zhu BT: Upregulated cyclin
B1/CDK1 mediates apoptosis following 2-methoxyestradiol-induced
mitotic catastrophe: Role of Bcl-XL phosphorylation.
Steroids. 150(108381)2019.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Choi HJ and Zhu BT: Role of cyclin B1/Cdc2
in mediating Bcl-XL phosphorylation and apoptotic cell death
following nocodazole-induced mitotic arrest. Mol Carcinog.
53:125–137. 2014.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Harley ME, Allan LA, Sanderson HS and
Clarke PR: Phosphorylation of Mcl-1 by CDK1-cyclin B1 initiates its
Cdc20-dependent destruction during mitotic arrest. EMBO J.
29:2407–2420. 2010.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Guo W, Huang J, Lei P, Guo L and Li X:
LncRNA SNHG1 promoted HGC-27 cell growth and migration via the
miR-140/ADAM10 axis. Int J Biol Macromol. 122:817–823.
2019.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Li Z, Li X, Du X, Zhang H, Wu Z, Ren K and
Han X: The Interaction Between lncRNA SNHG1 and miR-140 in
Regulating Growth and Tumorigenesis via the TLR4/NF-κB pathway in
Cholangiocarcinoma. Oncol Res. 27:663–672. 2019.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Lan X and Liu X: LncRNA SNHG1 functions as
a ceRNA to antagonize the effect of miR-145a-5p on the
down-regulation of NUAK1 in nasopharyngeal carcinoma cell. J Cell
Mol Med. 23:2351–2361. 2019.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Yu Y, Zhang M, Wang N, Li Q, Yang J, Yan
S, He X, Ji G and Miao L: Epigenetic silencing of tumor suppressor
gene CDKN1A by oncogenic long non-coding RNA SNHG1 in
cholangiocarcinoma. Cell Death Dis. 9(746)2018.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Liu J, Zhang C, Wang J, Hu W and Feng Z:
The regulation of ferroptosis by tumor suppressor p53 and its
pathway. Int J Mol Sci. 21(8387)2020.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Lai W, Zhu W, Li X, Han Y, Wang Y, Leng Q,
Li M and Wen X: GTSE1 promotes prostate cancer cell proliferation
via the SP1/FOXM1 signaling pathway. Lab Invest. 101:554–563.
2021.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Chen W, Wang H, Lu Y, Huang Y, Xuan Y, Li
X, Guo T, Wang C, Lai D, Wu S, et al: GTSE1 promotes tumor growth
and metastasis by attenuating of KLF4 expression in clear cell
renal cell carcinoma. Lab Invest. 102:1011–1022. 2022.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Stoyanova T, Roy N, Kopanja D,
Raychaudhuri P and Bagchi S: DDB2 (damaged-DNA binding protein 2)
in nucleotide excision repair and DNA damage response. Cell Cycle.
8:4067–4071. 2009.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Hung Y, Huang K, Chen P, Li JL, Lu SH,
Chang JC, Lin HY, Lo WC, Huang SY, Lee TT, et al: UQCRC1 engages
cytochrome c for neuronal apoptotic cell death. Cell Rep.
36(109729)2021.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Lin CH, Tsai PI, Lin HY, Hattori N,
Funayama M, Jeon B, Sato K, Abe K, Mukai Y, Takahashi Y, et al:
Mitochondrial UQCRC1 mutations cause autosomal dominant
parkinsonism with polyneuropathy. Brain. 143:3352–3373.
2020.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Wang Q, Li M, Gan Y, Jiang S, Qiao J,
Zhang W, Fan Y, Shen Y, Song Y, Meng Z, et al: Mitochondrial
Protein UQCRC1 is Oncogenic and a potential therapeutic target for
pancreatic cancer. Theranostics. 10:2141–2157. 2020.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Torricelli F, Saxena A, Nuamah R, Neat M,
Harling L, Ng W, Spicer J, Ciarrocchi A and Bille A: Genomic
analysis in short- and long-term patients with malignant pleura
mesothelioma treated with palliative chemotherapy. Eur J Cancer.
132:104–111. 2020.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Sun X, Huang T, Liu Z, Sun M and Luo S:
LncRNA SNHG7 contributes to tumorigenesis and progression in breast
cancer by interacting with miR-34a through EMT initiation and the
Notch-1 pathway. Eur J Pharmacol. 856(172407)2019.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Wang W, Chen S, Song X, Gui J, Li Y and Li
M: ELK1/lncRNA-SNHG7/miR-2682-5p feedback loop enhances bladder
cancer cell growth. Life Sci. 262(118386)2020.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Guo L, Lu J, Gao J, Li M, Wang H and Zhan
X: The function of SNHG7/miR-449a/ACSL1 axis in thyroid cancer. J
Cell Biochem. 121:4034–4042. 2020.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Wang J, Zhang S, Li X and Gong M: LncRNA
SNHG7 promotes cardiac remodeling by upregulating ROCK1 via
sponging miR-34-5p. Aging (Albany NY). 12:10441–10456.
2020.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Liu J, Yao L, Zhang M, Jiang J, Yang M and
Wang Y: Downregulation of LncRNA-XIST inhibited development of
non-small cell lung cancer by activating miR-335/SOD2/ROS signal
pathway mediated pyroptotic cell death. Aging (Albany NY).
11:7830–7846. 2019.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Shenouda SM, Widlansky ME, Chen K, Xu G,
Holbrook M, Tabit CE, Hamburg NM, Frame AA, Caiano TL, Kluge MA, et
al: Altered mitochondrial dynamics contributes to endothelial
dysfunction in diabetes mellitus. Circulation. 124:444–453.
2011.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Rovira-Llopis S, Banuls C, Diaz-Morales N,
Hernandez-Mijares A, Rocha M and Victor VM: Mitochondrial dynamics
in type 2 diabetes: Pathophysiological implications. Redox Biol.
11:637–645. 2017.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Pinti MV, Fink GK, Hathaway QA, Durr AJ,
Kunovac A and Hollander JM: Mitochondrial dysfunction in type 2
diabetes mellitus: An organ-based analysis. Am J Physiol Endocrinol
Metab. 316:E268–E285. 2019.PubMed/NCBI View Article : Google Scholar
|
